Status:
UNKNOWN
A Clinical Study: the Antibacterial Effect of Insoluble Antibacterial Nanoparticles (IABN) Incorporated in Dental Materials for Root Canal Treatment
Lead Sponsor:
Hadassah Medical Organization
Conditions:
Endodontic Treatment
Irreversible Pulpitis
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
The effect of Antibacterial Nanoparticles, Incorporated in root canal sealer material and in provisional restoration is going to be examined. Two different tests are planned: (1) clinical and radiolog...
Detailed Description
1. patients with molar teeth diagnosed with healthy pulp or irreversible pulpitis, and need root canal treatment, will be asked to participate in the study. After cleaning the teeth following a standa...
Eligibility Criteria
Inclusion
- Needs root canal treatment
- For the provisional restoration- molar teeth with class II restoration
- For the provisional restoration-healty/ uninfected teeth
- For the root canal sealer- single root canal
- For root canal sealer-infected teeth
Exclusion
- systemic health problems
- Pregnant women
- The use of antiseptic mouth rinse or antibiotic Up to 2 weeks before the beginning of study
Key Trial Info
Start Date :
July 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2015
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT01167985
Start Date
July 1 2013
End Date
December 1 2015
Last Update
July 23 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hadassah Medical Organization
Jerusalem, Israel